Novo Nordisk Inc. v. Brooksville Pharmaceuticals Inc.
| Novo Nordisk Inc. |
| Brooksville Pharmaceuticals Inc. |
| Dennis M. McClelland |
| 8:2023cv01503 |
| July 6, 2023 |
| US District Court for the Middle District of Florida |
| William F Jung |
| Thomas G Wilson |
| Personal Property: Other |
| 28 U.S.C. § 1332 Diversity-Deceptive Trade Practices |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 21, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 37
Unopposed MOTION for Gregory L. Halperin to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21490282 for $150 by Novo Nordisk Inc.. (Attachments: #1 Certificate of Good Standing)(Cohen, Jordan) Motions referred to Magistrate Judge Thomas G. Wilson.
|
|
Filing 36
Unopposed MOTION for Michael X. Imbroscio to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21490278 for $150 by Novo Nordisk Inc.. (Attachments: #1 Certificate of Good Standing)(Cohen, Jordan) Motions referred to Magistrate Judge Thomas G. Wilson.
|
|
Filing 35
Unopposed MOTION for Amee M. Frodle to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21490270 for $150 by Novo Nordisk Inc.. (Attachments: #1 Certificate of Good Standing)(Cohen, Jordan) Motions referred to Magistrate Judge Thomas G. Wilson.
|
|
Filing 34
NOTICE of Attorney Appearance by Jordan Scott Cohen on behalf of Novo Nordisk Inc. (Cohen, Jordan)
|
|
Filing 33
ORDER granting #17 Motion to Dismiss without prejudice. Should Plaintiff chose to amend, it should do so within twenty-one (21) days. Signed by Judge William F. Jung on 11/8/2023. (NME)
|
|
Filing 32
TRANSCRIPT of TELEPHONIC MOTION HEARING held on 10/5/23 before Judge WILLIAM F. JUNG. Court Reporter/Transcriber: TRACEY AURELIO. Email address: tracey_aurelio@flmd.uscourts.gov. Telephone number: 813-301-5448. NOTICE TO THE PARTIES - The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such notice is filed, the transcript may be made remotely available to the public without redaction after ninety (90) calendar days. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER or purchased through the Court Reporter. Redaction Request due 11/6/2023. Redacted Transcript Deadline set for 11/16/2023. Release of Transcript Restriction set for 1/16/2024. (TVA)
|
|
Filing 31
Minute Entry. Telephonic Proceedings held before Judge William F. Jung: MOTION HEARING held on 10/5/2023 re #17 MOTION to Dismiss Complaint filed by Brooksville Pharmaceuticals Inc. Court Reporter: Tracey Aurelio (JCG)
|
|
Filing 30
ORDER granting #22 Motion to Appear Pro Hac Vice. Accordingly, Jeffrey S. Bucholtz is admitted in this court pro hac vice. Signed by Magistrate Judge Thomas G. Wilson on 10/2/2023. (KMN)
|
|
Filing 29
ORDER granting #15 Motion to Appear Pro Hac Vice; granting #16 Motion to Appear Pro Hac Vice. Accordingly, Aaron S. Craig and Joseph N Akrotirianakis are admitted in this court pro hac vice. Signed by Magistrate Judge Thomas G. Wilson on 10/2/2023. (KMN)
|
|
Filing 28
NOTICE of supplemental authority by Brooksville Pharmaceuticals Inc. (Modafferi, Matthew) Modified text on 10/3/2023 (GL).
|
|
Filing 27
REPLY to Response to Motion re #17 MOTION to Dismiss Complaint filed by Brooksville Pharmaceuticals Inc.. (Modafferi, Matthew)
|
|
Filing 26
RESPONSE in Opposition re #17 MOTION to Dismiss Complaint filed by Novo Nordisk Inc.. (Kavanaugh, Samantha)
|
|
Filing 25
NOTICE of Rescheduling Telephonic Hearing (as to TIME only) on #17 MOTION to Dismiss Complaint. Motion Hearing set for 10/5/2023 at 8:30 AM before Judge William F. Jung. Counsel are directed to call the reserved conference toll free number at 1-888-557-8511. Enter the access code: 4744914 followed by the # (pound) key. You will be prompted to enter the security code: 1503 followed by the # (pound) key. Please call in at least 10 minutes before the scheduled hearing. (CCB) Modified text on 9/6/2023 (GL).
|
|
Filing 24
NOTICE of Rescheduling Telephonic Hearing (previously set for 9/15/2023) on #17 MOTION to Dismiss Complaint. Motion Hearing set for 10/5/2023 at 9:30 AM before Judge William F. Jung. Counsel are directed to call the reserved conference toll free number at 1-888-557-8511. Enter the access code: 4744914 followed by the # (pound) key. You will be prompted to enter the security code: 1503 followed by the # (pound) key. Please call in at least 10 minutes before the scheduled hearing.(CCB)
|
|
Filing 23
ENDORSED ORDER granting #21 Plaintiff's unopposed Motion for Extension of Time to File a response to the motion to dismiss on or before 9/15/2023. The hearing will be reset by separate notice. Signed by Judge William F. Jung on 8/30/2023. (CCB)
|
|
Filing 22
Unopposed MOTION for Jeffrey S. Bucholtz to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21202350 for $150 by Novo Nordisk Inc. (Price, Patrick) Motions referred to Magistrate Judge Thomas G. Wilson. Modified text on 8/31/2023 (MCB).
|
|
Filing 21
Unopposed MOTION to Extend Deadline to Oppose Motion to Dismiss and to Respectfully Request Modification of Hearing Date by Novo Nordisk Inc.. (Kavanaugh, Samantha) (Modified on 8/29/2023 to edit docket text) (JDR).
|
|
Filing 20
NOTICE of Telephonic Hearing on #17 MOTION to Dismiss Complaint. Motion Hearing set for 9/15/2023 at 9:30 AM before Judge William F. Jung. Counsel are directed to call the reserved conference toll free number at 1-888-557-8511. Enter the access code: 4744914 followed by the # (pound) key. You will be prompted to enter the security code: 1503 followed by the # (pound) key. Please call in at least 10 minutes before the scheduled hearing.(CCB)
|
|
Filing 19
MEMORANDUM in support re #17 Motion to Dismiss filed by Brooksville Pharmaceuticals Inc.. (Attachments: #1 Declaration)(Modafferi, Matthew)
|
|
Filing 18
**Counsel called and will refile corrected version** MEMORANDUM in support re #17 Motion to Dismiss filed by Brooksville Pharmaceuticals Inc. (Attachments: #1 Declaration)(Modafferi, Matthew) Modified text on 8/15/2023 (MCB).
|
|
Filing 17
MOTION to Dismiss Complaint by Brooksville Pharmaceuticals Inc.. (Modafferi, Matthew)
|
|
Filing 16
Unopposed MOTION for Joseph N. Akrotirianakis to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21107212 for $150 by Novo Nordisk Inc.. (Price, Patrick) Motions referred to Magistrate Judge Thomas G. Wilson.
|
|
Filing 15
Unopposed MOTION for Aaron S. Craig to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21106666 for $150 by Novo Nordisk Inc.. (Price, Patrick) Motions referred to Magistrate Judge Thomas G. Wilson.
|
|
Filing 14
ENDORSED ORDER granting Defendant's unopposed #13 Motion for Extension of Time to File a response to the Complaint on or before 8/14/2023. Signed by Judge William F. Jung on 7/25/2023. (CCB)
|
|
Filing 13
Unopposed MOTION for Extension of Time to File Response to the Complaint by Brooksville Pharmaceuticals Inc.. (Modafferi, Matthew)
|
|
Set/reset deadlines/hearings: for Brooksville Pharmaceuticals Inc.. Answer due by 8/14/2023. (LAB)
|
|
Filing 12
ORDER granting #11 Motion to Appear Pro Hac Vice. Signed by Magistrate Judge Thomas G. Wilson on 7/20/2023. (KMN)
|
|
Filing 11
Unopposed MOTION for Matthew J. Modafferi to appear pro hac vice, Special Admission fee paid, Receipt No. AFLMDC-21056867 for $150 by Brooksville Pharmaceuticals Inc. (Modafferi, Matthew) Motions referred to Magistrate Judge Thomas G. Wilson. Modified on 7/20/2023 to edit docket text (AJS).
|
|
Filing 10
RETURN of service executed on 07/10/23 by Novo Nordisk Inc. as to Brooksville Pharmaceuticals Inc. (Price, Patrick) Modified text on 7/18/2023 (MCB).
|
|
Filing 9
NOTICE of Lead Counsel Designation by Patrick Brinson Price on behalf of Novo Nordisk Inc.. Lead Counsel: Patrick Price. (Price, Patrick)
|
|
Filing 8
CORPORATE Disclosure Statement by Novo Nordisk Inc. identifying Corporate Parent Novo Nordisk US Holdings, Inc., Corporate Parent Novo Nordisk US Commercial Holdings, Inc., Corporate Parent Novo Nordisk A/S for Novo Nordisk Inc. (Kavanaugh, Samantha) Modified on 7/13/2023 to edit text (ABC).
|
|
Filing 7
ORDER appointing Dennis M. McClelland as mediator in this action. Signed by Judge William F. Jung on 7/11/2023. (CCB)
|
|
Filing 6
NOTICE informing the parties that they may consent to the jurisdiction of a United States magistrate judge by filing Form AO 85 Notice, Consent, and Reference of a Civil Action to a Magistrate Judge using the event Consent to Jurisdiction of US Magistrate Judge. (Signed by Deputy Clerk). (JCG)
|
|
Filing 5
NOTICE of Local Rule 1.07(c), Local Rule 3.02(a)(2), and Local Rule 3.03. -Local Rule 1.07(c) requires lead counsel to promptly file a Notice of a Related Action that identifies and describes any related action pending in the Middle District or elsewhere. -Local Rule 3.02(a)(2) requires the parties in every civil proceeding, except those described in subsection (d), to file a case management report (CMR) using the uniform form at www.flmd.uscourts.gov. The CMR must be filed (1) within forty days after any defendant appears in an action originating in this court, (2) within forty days after the docketing of an action removed or transferred to this court, or (3) within seventy days after service on the United States attorney in an action against the United States, its agencies or employees. Judges may have a special CMR form for certain types of cases. These forms can be found at www.flmd.uscourts.gov under the Forms tab for each judge. -Local Rule 3.03 requires each party to file a disclosure statement. Counsel must make their disclosures using the standard court form. The Disclosure Statement form can be found at www.flmd.uscourts.gov. (Signed by Deputy Clerk). (JCG)
|
|
Filing 4
SUMMONS issued as to Brooksville Pharmaceuticals Inc. (BGR)
|
|
Filing 3
NEW CASE ASSIGNED to Judge William F. Jung and Magistrate Judge Thomas G. Wilson. New case number: 8:23-cv-1503-WFJ-TGW. (ARC)
|
|
Filing 2
CORPORATE Disclosure Statement by Novo Nordisk Inc. identifying Corporate Parent Novo Nordisk US Holdings, Inc., Corporate Parent Novo Nordisk US Commercial Holdings, Inc., Corporate Parent Novo Nordisk A/S for Novo Nordisk Inc... (Kavanaugh, Samantha)
|
|
Filing 1
COMPLAINT against Brooksville Pharmaceuticals Inc. (Filing fee $402 receipt number AFLMDC-21012901) filed by Novo Nordisk Inc.. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons)(Kavanaugh, Samantha)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
